Patent details
LUC00090
Product Name:
"Combinaison comprenant du dolutégravir ou un sel pharmaceutiquement acceptable de celui-ci (par exemple le dolutégravir sodique) et la rilpivirine ou un sel pharmaceutiquement acceptable de celui-ci (par exemple le chlorhydrate de rilpivirine)"
Basic Information
- Publication number:
- LUC00090
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
-
EP151649316
- Legal Status:
- Invalid
- Application number:
- LUC00090
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/18/1282
- Marketing Authorization Type:
-
- Marketing Authorization Date:
- 18/05/2018
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 31/10/2018
- First Marketing Authorization date:
- 18/05/2018
- Grant date:
- 08/01/2019
- Activation date:
- Publication date:
- 02/11/2018
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 18/05/2033
- SPC Extension Expiration:
- 18/05/2033
- Rejection date:
- Withdrawal date:
Owner
- From:
- 31/10/2018
-
-
- Name:
- VIIV Healthcare Company
- Address:
- 251 Little Falls Drive, Wilmington, DE 19808, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 31/10/2018
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2018/13
- Publication date:
- 13/12/2018
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2019/02
- Publication date:
- 22/02/2019
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
3
- Bulletin Heading:
- VRV
- Bulletin edition number:
- 2024/05
- Publication date:
- 03/04/2024
- Description:
- Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law)
Renunciation to a patent or supplementary protection certificate (Art. 72 of the law)
Rejected applications for extensions for pediatric use of supplementary protections certificates
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-